The use of imaging for electrophysiological and devices procedures: A report from the first European Heart Rhythm Association Policy Conference, jointly organized with the European Association of Cardiovascular Imaging (EACVI), the Council of Cardiovascular Imaging and the European Society of Cardiac Radiology

Europace

Volumn 15, Issue 7, 2013, Pages 927-936

  Blomström Lundqvist, Carina ^a   Auricchio, Angelo ^b   Brugada, Josep ^c   Boriani, Giuseppe ^d   Bremerich, Jens ^e   Cabrera, Jose Angel ^f   Frank, Herbert ^g   Gutberlet, Matthias ^h   Heidbuchel, Hein ⁱ   Kuck, Karl Heinz ^j   Lancellotti, Patrizio ^k   Rademakers, Frank ^l   Winkels, Gerard ^m   Wolpert, Christian ⁿ   Vardas, Panos E ^o  

^a UPPSALA UNIVERSITY   (Sweden)

^b DIVISION OF CARDIOLOGY   (Switzerland)

^c UNIVERSITY OF BARCELONA   (Spain)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e UNIVERSITY HOSPITAL BASEL   (Switzerland)

^f Hospital Universitario Quiron   (Spain)

^g Landeskrankenhaus Tulln   (Austria)

^h UNIVERSITY OF LEIPZIG   (Germany)

ⁱ UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^j Asklepios Hospital St Georg   (Germany)

^k UNIVERSITY OF LIÈGE   (Belgium)

^l UNIVERSITY OF LEUVEN   (Belgium)

^m PHILIPS HEALTHCARE   (United States)

ⁿ Department of Internal Medicine Cardiology Nephrology and Intensive Care Medicine   (Germany)

^o UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ABLATION THERAPY; ARTICLE; ARTIFICIAL HEART PACEMAKER; CARDIAC IMAGING; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOLOGIST; CARDIOVASCULAR EQUIPMENT; CARDIOVASCULAR MAGNETIC RESONANCE; CATHETER ABLATION; CONSENSUS; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FLUOROSCOPY; HEALTH CARE ACCESS; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART ELECTROPHYSIOLOGY; HEART RHYTHM; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MEDICAL DEVICE COMPLICATION; MEDICAL EDUCATION; MEDICAL SOCIETY; PATIENT SELECTION; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REIMBURSEMENT; TELEMEDICINE; TREATMENT INDICATION;

CARDIAC PACING, ARTIFICIAL; CARDIOLOGY; CATHETER ABLATION; CONSENSUS; COST-BENEFIT ANALYSIS; DEFIBRILLATORS, IMPLANTABLE; DIAGNOSTIC IMAGING; EDUCATION, MEDICAL; ELECTRIC COUNTERSHOCK; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; EUROPE; EVIDENCE-BASED MEDICINE; HEALTH CARE COSTS; HUMANS; INSURANCE, HEALTH, REIMBURSEMENT; PACEMAKER, ARTIFICIAL; SOCIETIES, MEDICAL;

EID: 84879584722     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eut084     Document Type: Article

References (59)

1. European Heart Rhythm Association. EHRA White Book 2010 [Internet]. 2010. http://www.escardio.org/communities/EHRA/publications/Pages/white-book-project. aspx (20 April 2011, date last accessed).
2. Otero HJ, Rybicki FJ, Greenberg D, Mitsouras D, Mendoza JA, Neumann PJ. Cost-effective diagnostic cardiovascular imaging: when does it provide good value for the money? Int J Cardiovasc Imaging 2010;26:605-12.
3. Leo CG, Carpeggiani C, Picano E. Cost and benefit in cardiovascular imaging: the quest for economic sustainability. Int J Cardiovasc Imaging 2010;26:613-6.
4. Fraser AG. The future of cardiovascular imaging and non-invasive diagnosis: a joint statement from the European Association of Echocardiography, the Working Groups on Cardiovascular Magnetic Resonance, Computers in Cardiology, and Nuclear Cardiology, of the European Society of Cardiology, the European Association of Nuclear Medicine, and the Association for European Paediatric Cardiology. Eur Heart J 2006;27:1750-3.
5. Dickstein K, Filippatos G, McMurray JJV, Ponikowski P, Poole-Wilson PA, Strömberg A et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. Eur Heart J 2008;29:2388-442.
6. Dickstein K, Vardas PE, Auricchio A, Daubert JC, Linde C, McMurray J et al. 2010 Focused update of ESC guidelines on device therapy in heart failure: an update of the 2008 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. Europace 2010;12:1526-36.
7. McAlister FA, Ezekowitz J, Hooton N, Vandermeer B, Spooner C, Dryden DM et al. Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review. JAMA-J Am Med Assoc 2007;297:2502-14.
8. Lafitte S, Reant P, Serri K, Roudaut R. Echocardiographic algorithm for cardiac resynchronization. Echocardiography 2008;25:1040-6.
9. Chung ES, Leon AR, Tavazzi L, Sun J-P, Nihoyannopoulos P, Merlino J et al. Results of the predictors of response to CRT (PROSPECT) trial. Circulation 2008;117: 2608-16.
10. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP et al., MADIT-CRT Trial Investigators. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009;361:1329-38.
11. Gorcsan J III, Abraham T, Agler DA, Bax JJ, Derumeaux G, Grimm RA et al. Echo-cardiography for cardiac resynchronization therapy: recommendations for performance and reporting-a report from the American Society of Echocardiography Dyssynchrony Writing Group endorsed by the Heart Rhythm Society. J Am Soc Echocardiog 2008;21:191-213.
12. Duckett SG, Chiribiri A, Ginks MR, Sinclair S, Knowles BR, Botnar R et al. Cardiac MRI to investigate myocardial scar and coronary venous anatomy using a slow infusion of dimeglumine gadobenate in patients undergoing assessment for cardiac resynchronization therapy. J Magn Reson Imaging 2011;33:87-95.
13. Bertaglia E, Zoppo F, Tondo C, Colella A, Mantovan R, Senatore G et al. Early complications of pulmonary vein catheter ablation for atrial fibrillation: a multi-center prospective registry on procedural safety. Heart Rhythm 2007;4:1265-71.
14. Puwanant S, Varr BC, Shrestha K, Hussain SK, Tang WHW, Gabriel RS et al. Role of the CHADS2 score in the evaluation of thromboembolic risk in patients with atrial fibrillation undergoing transesophageal echocardiography before pulmonary vein isolation. J Am Coll Cardiol 2009;54:2032-9.
15. Cappato R, Calkins H, Chen S-A, Davies W, Iesaka Y, Kalman J et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol 2010;3:32-8.
16. Lickfett L, Hackenbroch M, Lewalter T, Selbach S, Schwab JO, Yang A et al. Cerebral diffusion-weighted magnetic resonance imaging: a tool to monitor the thrombogenicity of left atrial catheter ablation. J. Cardiovasc Electrophysiol 2006; 17:1-7.
17. Gaita F, Caponi D, Pianelli M, Scaglione M, Toso E, Cesarani F et al. Radiofre-quency catheter ablation of atrial fibrillation: a cause of silent thromboembolism? Magnetic resonance imaging assessment of cerebral thromboembolism in patients undergoing ablation of atrial fibrillation. Circulation 2010;122:1667-73.
18. He H, Kang J, Tao H, Zhen B, Zhang M, Long D et al. Conventional oral anticoa-gulation may not replace prior transesophageal echocardiography for the patients with planned catheter ablation for atrial fibrillation. J Interv Card Electrophysiol 2009;24:19-26.
19. Wallace TW, Atwater BD, Daubert JP, Voora D, Crowley AL, Bahnson TD et al. Prevalence and clinical characteristics associated with left atrial appendage thrombus in fully anticoagulated patients undergoing catheter-directed atrial fibrillation ablation. J Cardiovasc Electrophysiol 2010;21:849-52.
20. Calvo N, Mont L, Vidal B, Nadal M, Montserrat S, Andreu D et al. Usefulness of transoesophageal echocardiography before circumferential pulmonary vein ablation in patients with atrial fibrillation: is it really mandatory? Europace 2011;13: 486-91.
21. Daniel WG, Erbel R, Kasper W, Visser CA, Engberding R, Sutherland GR et al. Safety of transesophageal echocardiography. A multicenter survey of 10, 419 examinations. Circulation 1991;83:817-21.
22. Gimbel JR, Bailey SM, Tchou PJ, Ruggieri PM, Wilkoff BL. Strategies for the safe magnetic resonance imaging of pacemaker-dependent patients. Pacing Clin Electro-physiol 2005;28:1041-6.
23. Naehle CP, Strach K, Thomas D, Meyer C, Linhart M, Bitaraf S et al. Magnetic resonance imaging at 1.5-T in patients with implantable cardioverter-defibrillators. J Am Coll Cardiol 2009;54:549-55.
24. Shinbane JS, Colletti PM, Shellock FG. MR in patients with pacemakers and ICDs: defining the issues. J Cardiovasc Magn Reson 2007;9:5-13.
25. Kalin R, Stanton MS. Current clinical issues for MRI scanning of pacemaker and defibrillator patients. Pacing Clin Electrophysiol 2005;28:326-8.
26. Peters DC, Wylie JV, Hauser TH, Kissinger KV, Botnar RM, Essebag V et al. Detection of pulmonary vein and left atrial scar after catheter ablation with three-dimensional navigator-gated delayed enhancement MR imaging: initial experience. Radiology 2007;243:690-5.
27. Oakes RS, Badger TJ, Kholmovski EG, Akoum N, Burgon NS, Fish EN et al. Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation. Circulation 2009;119:1758-67.
28. Anné W, Willems R, Roskams T, Sergeant P, Herijgers P, Holemans P et al. Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation. Cardiovasc Res 2005;67:655-66.
29. Tanaka K, Zlochiver S, Vikstrom KL, Yamazaki M, Moreno J, Klos M et al. Spatial distribution of fibrosis governs fibrillation wave dynamics in the posterior left atrium during heart failure. Circ Res 2007;101:839-47.
30. Lehmkuhl L, Gosch D, Nagel HD, Stumpp P, Kahn T, Gutberlet M. Quantification of radiation dose savings in cardiac computed tomography using prospectively triggered mode and ECG pulsing: a phantom study. Eur Radiol 2010;20:2116-25.
31. Hsieh J, Londt J, Vass M, Li J, Tang X, Okerlund D. Step-and-shoot data acquisition and reconstruction for cardiac X-ray computed tomography. Med Phys 2006; 33:4236-48.
32. Kaufmann PA, Knuuti J. Ionizing radiation risks of cardiac imaging: estimates of the immeasurable. Eur Heart J 2010;32:269-71.
33. Shpun S, Gepstein L, Hayam G, Ben-Haim SA. Guidance of radiofrequency endo-cardial ablation with real-time three-dimensional magnetic navigation system. Circulation 1997;96:2016-21.
34. Schilling RJ, Peters NS, Davies DW. Simultaneous endocardial mapping in the human left ventricle using a noncontact catheter: comparison of contact and reconstructed electrograms during sinus rhythm. Circulation 1998;98:887-98.
35. Khaykin Y, Skanes A, Whaley B, Hill C, Beardsall M, Seabrook C et al. Real-time integration of 2D intracardiac echocardiography and 3D electroanatomical mapping to guide ventricular tachycardia ablation. Heart Rhythm 2008; 5:1396-402.
36. Schneider MAE, Ndrepepa G, Dobran I, Schreieck J, Weber S, Plewan A et al. LocaLisa catheter navigation reduces fluoroscopy time and dosage in ablation of atrial flutter: a prospective randomized study. J Cardiovasc Electrophysiol 2003; 14:587-90.
37. Wood MA, Christman PJ, Shepard RK, Ellenbogen KA. Use of a non-fluoroscopic catheter navigation system for pulmonary vein isolation. J Interv Card Electrophysiol 2004;10:165-70.
38. Kesek M, Wallenius N, Rönn F, Höglund N, Jensen S. Reduction of fluoroscopy duration in radiofrequency ablation obtained by the use of a non-fluoroscopic catheter navigation system. Europace 2006;8:1027-30.
39. US Dept of Health & Human Services. Medical Expenditure Panel Survey Home [Internet]. http://www.meps.ahrq.gov/mepsweb/(27 April 2011, date last accessed).
40. Shaw LJ, Min JK, Hachamovitch R, Peterson ED, Hendel RC, Woodard PK et al. Cardiovascular imaging research at the crossroads. JACC Cardiovasc Imaging 2010;3:316-24.
41. Vassiliou A. Together for Achieving Sustainable Healthcare in the EU [Internet]. European Commission; 2009. http://europa.eu/rapid/ pressReleasesAction.do?reference= SPEECH/09/444&format=HTML&aged= 1&language=EN&guiLanguage=en (27 April 2011, date last accessed).
42. Hollingworth W, Jarvik JG. Technology assessment in radiology: putting the evidence in evidence-based radiology. Radiology 2007;244:31-8.
43. Mackenzie R, Dixon AK. Measuring the effects of imaging: an evaluative framework. Clin Radiol 1995;50:513-8.
44. Neumann PJ, Weinstein MC. Legislating against use of cost-effectiveness information. N Engl J Med 2010;363:1495-7.
45. National Institute for Health and Clinical Excellence. Value Based Pricing: Consultation Response [Internet]. 2011. http://www.nice.org.uk/media/ D7E/05/NICEVBPConsultation.pdf
46. Hutton J, Trueman P, Henshall C. Coverage with evidence development: an examination of conceptual and policy issues. Int J Technol Assess Health Care 2007;23:425-32.
47. Klemp M, Frønsdal KB, Facey K. What principles should govern the use of managed entry agreements? Int J Technol Assess Health Care 2011;27:77-83.
48. Boriani G, Burri H, Mantovani LG, Maniadakis N, Leyva F, Kautzner J et al. Device therapy and hospital reimbursement practices across European countries: a heterogeneous scenario. Europace 2011;13(Suppl 2):ii59-65.
49. Boriani G, Maniadakis N, Auricchio A, Vardas P. Health economics and outcomes research: a new challenge and field of action for the European Heart Rhythm Association. Europace 2010;12:601-3.
50. Fattore G, Maniadakis N, Mantovani LG, Boriani G. Health technology assessment: what is it? Current status and perspectives in the field of electrophysiology. Europace 2011;13(Suppl 2):ii49-53.
51. Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med 2007; 356:2388-98.
52. Duchateau N, De Craene M, Piella G, Silva E, Doltra A, Sitges M et al. A spatio-temporal statistical atlas of motion for the quantification of abnormal myocardial tissue velocities. Med Image Anal 2011;15:316-28.
53. Kirişli HA, Schaap M, Klein S, Papadopoulou SL, Bonardi M, Chen CH et al. Evaluation of a multi-atlas based method for segmentation of cardiac CTA data: a large-scale, multicenter, and multivendor study. Med Phys 2010;37:6279-91.
54. Tao Q, Milles J, Zeppenfeld K, Lamb HJ, Bax JJ, Reiber JHC et al. Automated segmentation of myocardial scar in late enhancement MRI using combined intensity and spatial information. Magn Reson Med 2010;64:586-94.
55. Merino JL, Arribas F, Botto GL, Huikuri H, Kraemer LI, Linde C et al. Core curriculum for the heart rhythm specialist: executive summary. Europace 2009;11: 1381-6.
56. Lopez-Sendon J, Mills P, Weber H, Michels R, Mario CD, Filippatos GS et al. Recommendations on sub-speciality accreditation in cardiology: The Coordination Task Force on Sub-speciality Accreditation of the European Board for the Speciality of Cardiology. Eur Heart J 2007;28:2163-71.
57. Popescu BA, Andrade MJ, Badano LP, Fox KF, Flachskampf FA, Lancellotti P et al. European Association of Echocardiography recommendations for training, competence, and quality improvement in echocardiography. Eur J Echocardiog 2009; 10:893-905.
58. Fraser AG, Dunstan FD. On the impossibility of being expert. BMJ 2010;341:c6815.
59. Tricoci P, Allen JM, Kramer JM, Califf RM, Smith SC. Scientific evidence underlying the ACC/AHA clinical practice guidelines. JAMA 2009;301:831-41.